{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:07:11Z","timestamp":1769267231721,"version":"3.49.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.bone.2015.05.024","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T01:02:57Z","timestamp":1432861377000},"page":"143-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Inflammatory signaling induced bone loss"],"prefix":"10.1016","volume":"80","author":[{"given":"Steven R.","family":"Goldring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2015.05.024_bb0005","series-title":"Kelly's textbook of rheumatology","first-page":"1","article-title":"Chapter 1: biology of the normal joint","author":"Goldring","year":"2013"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1469-7580.2006.00540.x","article-title":"Where tendons and ligaments meet bone: attachment sites (\u2018entheses\u2019) in relation to exercise and\/or mechanical load","volume":"208","author":"Benjamin","year":"2006","journal-title":"J Anat"},{"issue":"Pt 5","key":"10.1016\/j.bone.2015.05.024_bb0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1469-7580.2001.19950503.x","article-title":"The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites","volume":"199","author":"Benjamin","year":"2001","journal-title":"J Anat"},{"key":"10.1016\/j.bone.2015.05.024_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4419-0298-6_4","article-title":"The enthesis organ concept and its relevance to the spondyloarthropathies","volume":"649","author":"Benjamin","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bone.2015.05.024_bb0025","series-title":"Osteoimmunology","first-page":"301","article-title":"The role of the immune system in the bone loss of inflammatory arthritis","author":"Goldring","year":"2011"},{"issue":"13 Suppl","key":"10.1016\/j.bone.2015.05.024_bb0030","article-title":"Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future","author":"Schett","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"9664","key":"10.1016\/j.bone.2015.05.024_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","article-title":"Rheumatoid arthritis","volume":"373","author":"Klareskog","year":"2009","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.bone.2015.05.024_bb0040","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"issue":"3 Suppl","key":"10.1016\/j.bone.2015.05.024_bb0045","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.rhu.0000166673.34461.33","article-title":"Immunologic mechanisms in the pathogenesis of rheumatoid arthritis","volume":"11","author":"Firestein","year":"2005","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.bone.2015.05.024_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/art.1780280105","article-title":"Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis","volume":"28","author":"Shimizu","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.bone.2015.05.024_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2008.099408","article-title":"Periarticular bone changes in rheumatoid arthritis: pathophysiological implications and clinical utility","volume":"68","author":"Goldring","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.bone.2015.05.024_bb0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/ard.2007.085985","article-title":"Cortical hand bone loss after 1year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up","volume":"68","author":"Hoff","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.bone.2015.05.024_bb0065","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/rheumatology\/keh385","article-title":"Predicting erosive disease in rheumatoid arthritis. A longitudinal study of changes in bone density using digital X-ray radiogrammetry: a pilot study","volume":"43","author":"Stewart","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.bone.2015.05.024_bb0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/art.1780270804","article-title":"Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion","volume":"27","author":"Bromley","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0075","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.bone.2015.05.024_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1359\/JBMR.0301233","article-title":"RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis","volume":"19","author":"Li","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.bone.2015.05.024_bb0085","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bone.2015.05.024_bb0090","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","article-title":"Osteoclasts are essential for TNF-alpha-mediated joint destruction","volume":"110","author":"Redlich","year":"2002","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.bone.2015.05.024_bb0095","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/acr.20004","article-title":"Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients","volume":"62","author":"Deodhar","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.bone.2015.05.024_bb0105","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/art.21824","article-title":"Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis","volume":"54","author":"Jarrett","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"22","key":"10.1016\/j.bone.2015.05.024_bb0110","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.bone.2015.05.024_bb0115","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.bone.2015.05.024_bb0120","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/annrheumdis-2013-204577","article-title":"Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"73","author":"Nam","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/annrheumdis-2012-202470","article-title":"Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement","volume":"72","author":"Schoels","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.bone.2015.05.024_bb0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","article-title":"Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.bone.2015.05.024_bb0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/annrheumdis-2012-202469","article-title":"Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions","volume":"72","author":"Smolen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/BOR.0000000000000069","article-title":"The interleukin-23\/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis","volume":"26","author":"Yeremenko","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.bone.2015.05.024_bb0150","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/ar3537","article-title":"Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis","volume":"13","author":"Guyot","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.bone.2015.05.024_bb0155","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2010.144998","article-title":"Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"70","author":"Buch","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bone.2015.05.024_bb0160","first-page":"1","article-title":"Effects of inflammatory and anti-inflammatory cytokines on the bone","volume":"10","author":"Schett","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"10.1016\/j.bone.2015.05.024_bb0165","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.bone.2015.05.024_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1749-6632.2009.05303.x","article-title":"New immune connections in osteoclast formation","volume":"1192","author":"Takayanagi","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.bone.2015.05.024_bb0175","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/1529-0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S","article-title":"Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"6717","key":"10.1016\/j.bone.2015.05.024_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0185","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T","article-title":"Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis","volume":"43","author":"Romas","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.bone.2015.05.024_bb0190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","article-title":"Involvement of receptor activator of nuclear factor kappaB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis","volume":"43","author":"Takayanagi","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.bone.2015.05.024_bb0195","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bone.2015.05.024_bb0200","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"issue":"27","key":"10.1016\/j.bone.2015.05.024_bb0205","doi-asserted-by":"crossref","first-page":"11394","DOI":"10.1073\/pnas.0701971104","article-title":"Pathological role of osteoclast costimulation in arthritis-induced bone loss","volume":"104","author":"Ochi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6759","key":"10.1016\/j.bone.2015.05.024_bb0210","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bone.2015.05.024_bb0215","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/art.10097","article-title":"Tumor necrosis factor-\u03b1-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin","volume":"46","author":"Redlich","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0220","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)64417-3","article-title":"Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis","volume":"161","author":"Romas","year":"2002","journal-title":"Am J Pathol"},{"issue":"6812","key":"10.1016\/j.bone.2015.05.024_bb0225","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0230","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbrc.2007.04.042","article-title":"Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells","volume":"357","author":"Kim","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.bone.2015.05.024_bb0235","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1002\/art.23138","article-title":"Treg cells suppress osteoclast formation: a new link between the immune system and bone","volume":"56","author":"Zaiss","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.bone.2015.05.024_bb0240","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.4049\/jimmunol.0903841","article-title":"Regulatory T cells protect from local and systemic bone destruction in arthritis","volume":"184","author":"Zaiss","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.bone.2015.05.024_bb0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bone.2015.05.024_bb0250","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.bone.2015.05.024_bb0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","article-title":"Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage","volume":"62","author":"Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bone.2015.05.024_bb0260","article-title":"Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA","author":"Hecht","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.bone.2015.05.024_bb0265","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.bone.2015.05.024_bb0270","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1359\/jbmr.090320","article-title":"Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis","volume":"24","author":"Walsh","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bone.2015.05.024_bb0275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nm0207-133","article-title":"Eating bone or adding it: the Wnt pathway decides","volume":"13","author":"Goldring","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0280","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00002281-200307000-00016","article-title":"Effects of rheumatoid arthritis on bone","volume":"15","author":"Haugeberg","year":"2003","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10.1016\/j.bone.2015.05.024_bb0285","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/ard.2003.016253","article-title":"Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density","volume":"63","author":"Lodder","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.bone.2015.05.024_bb0290","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","article-title":"Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis","volume":"54","author":"van Staa","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.bone.2015.05.024_bb0295","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00198-010-1517-6","article-title":"High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis","volume":"22","author":"Vis","year":"2011","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.bone.2015.05.024_bb0300","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/art.24551","article-title":"The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis","volume":"60","author":"Solomon","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.bone.2015.05.024_bb0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/ard.53.3.163","article-title":"Bone turnover in non-steroid treated rheumatoid arthritis","volume":"53","author":"Compston","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.bone.2015.05.024_bb0310","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/art.10616","article-title":"Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study","volume":"46","author":"Garnero","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.bone.2015.05.024_bb0315","first-page":"1282","article-title":"Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis","volume":"25","author":"Gough","year":"1998","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.bone.2015.05.024_bb0320","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semarthrit.2008.04.004","article-title":"Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy","volume":"39","author":"Barnabe","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.bone.2015.05.024_bb0325","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1196\/annals.1351.040","article-title":"Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis","volume":"1069","author":"Seriolo","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.bone.2015.05.024_bb0330","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2009.122325","article-title":"Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs","volume":"69","author":"Syversen","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.bone.2015.05.024_bb0335","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/ard.2005.044198","article-title":"Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis","volume":"65","author":"Vis","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.bone.2015.05.024_bb0340","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/art.21896","article-title":"The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction","volume":"54","author":"Geusens","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.bone.2015.05.024_bb0345","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3899\/jrheum.080356","article-title":"Circulating Dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanercept","volume":"35","author":"Garnero","year":"2008","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.bone.2015.05.024_bb0350","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3899\/jrheum.100089","article-title":"Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis","volume":"38","author":"Wang","year":"2011","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.bone.2015.05.024_bb0355","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/BOR.0000000000000089","article-title":"The pathogenesis, diagnosis and treatment of lupus nephritis","volume":"26","author":"Schwartz","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.bone.2015.05.024_bb0360","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.10753","article-title":"Jaccoud's arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging","volume":"48","author":"Ostendorf","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.bone.2015.05.024_bb0365","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/art.22578","article-title":"Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus","volume":"56","author":"Nzeusseu Toukap","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.bone.2015.05.024_bb0370","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.bone.2015.05.024_bb0375","first-page":"359","article-title":"Type I, interferon in systemic lupus erythematosus","volume":"316","author":"Crow","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"10.1016\/j.bone.2015.05.024_bb0380","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I, interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol"},{"issue":"33","key":"10.1016\/j.bone.2015.05.024_bb0385","doi-asserted-by":"crossref","first-page":"11917","DOI":"10.1073\/pnas.0502188102","article-title":"Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression","volume":"102","author":"Coelho","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0390","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/art.27312","article-title":"Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis","volume":"62","author":"Mensah","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.bone.2015.05.024_bb0395","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1186\/ar3104","article-title":"Prevalence and risk factors of vertebral compression fractures in female SLE patients","volume":"12","author":"Almehed","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.bone.2015.05.024_bb0400","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/art.21110","article-title":"Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus","volume":"52","author":"Bultink","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.bone.2015.05.024_bb0405","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","article-title":"HLA-B27 misfolding and ankylosing spondylitis","volume":"57","author":"Colbert","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bone.2015.05.024_bb0410","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/TACG.S37325","article-title":"The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis","volume":"7","author":"Tsui","year":"2014","journal-title":"Appl Clin Genet"},{"issue":"7","key":"10.1016\/j.bone.2015.05.024_bb0415","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11926-013-0342-2","article-title":"Osteoimmunology and bone homeostasis: relevance to spondyloarthritis","volume":"15","author":"Goldring","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.bone.2015.05.024_bb0420","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/ar2642","article-title":"Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis","volume":"11","author":"Lories","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bone.2015.05.024_bb0425","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis","volume":"4","author":"Braun","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.bone.2015.05.024_bb0430","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/art.11389","article-title":"Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis","volume":"48","author":"Lories","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.bone.2015.05.024_bb0435","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI23738","article-title":"Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis","volume":"115","author":"Lories","year":"2005","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.bone.2015.05.024_bb0440","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.rdc.2012.08.003","article-title":"Pathophysiology of new bone formation and ankylosis in spondyloarthritis","volume":"38","author":"Lories","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"10.1016\/j.bone.2015.05.024_bb0445","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","article-title":"Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis","volume":"60","author":"Appel","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.bone.2015.05.024_bb0450","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.59.2.135","article-title":"Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis\u2013cellularity correlates with the degree of enhancement detected by magnetic resonance imaging","volume":"59","author":"Bollow","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.bone.2015.05.024_bb0455","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4\u2212CD8\u2212 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.bone.2015.05.024_bb0460","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","article-title":"Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells","volume":"73","author":"Jacques","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.bone.2015.05.024_bb0465","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3899\/jrheum.120316","article-title":"Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton","volume":"39","author":"Klingberg","year":"2012","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.bone.2015.05.024_bb0470","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3833","article-title":"Osteoporosis in ankylosing spondylitis \u2014 prevalence, risk factors and methods of assessment","volume":"14","author":"Klingberg","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"6724","key":"10.1016\/j.bone.2015.05.024_bb0475","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bmj.300.6724.563","article-title":"Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis","volume":"300","author":"Ralston","year":"1990","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.bone.2015.05.024_bb0480","first-page":"138","article-title":"Bone mineral density in patients with psoriatic arthritis","volume":"28","author":"Frediani","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bone.2015.05.024_bb0485","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(89)92932-2","article-title":"Osteoporosis in early ankylosing spondylitis; a primary pathological event?","volume":"23","author":"Will","year":"1989","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bone.2015.05.024_bb0490","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/ard.62.10.1020","article-title":"Bone mineral density improvement in spondyloarthropathy after treatment with etanercept","volume":"62","author":"Marzo-Ortega","year":"2003","journal-title":"Ann Rheum Dis"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215002057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328215002057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T04:25:22Z","timestamp":1537590322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328215002057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":98,"alternative-id":["S8756328215002057"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2015.05.024","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory signaling induced bone loss","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2015.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}